Colgate-Palmolive Company $CL Shares Acquired by NEOS Investment Management LLC

NEOS Investment Management LLC grew its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 44.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 107,824 shares of the company’s stock after purchasing an additional 33,114 shares during the period. NEOS Investment Management LLC’s holdings in Colgate-Palmolive were worth $8,619,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Norges Bank purchased a new position in shares of Colgate-Palmolive in the second quarter worth approximately $960,390,000. Schroder Investment Management Group boosted its stake in Colgate-Palmolive by 242.3% in the 2nd quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company’s stock worth $483,962,000 after purchasing an additional 3,768,784 shares during the period. Pacer Advisors Inc. grew its position in Colgate-Palmolive by 3,052.2% during the 3rd quarter. Pacer Advisors Inc. now owns 2,697,047 shares of the company’s stock worth $215,602,000 after purchasing an additional 2,611,485 shares in the last quarter. Diamond Hill Capital Management Inc. raised its stake in Colgate-Palmolive by 46.7% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock valued at $645,719,000 after purchasing an additional 2,572,796 shares during the period. Finally, Acadian Asset Management LLC lifted its holdings in shares of Colgate-Palmolive by 42.9% in the second quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company’s stock valued at $556,663,000 after purchasing an additional 1,839,853 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on CL shares. Rothschild & Co Redburn set a $93.00 price target on Colgate-Palmolive in a report on Friday, February 13th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. The Goldman Sachs Group reissued a “buy” rating and issued a $94.00 price target on shares of Colgate-Palmolive in a research report on Saturday, January 31st. Jefferies Financial Group boosted their price objective on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Finally, Barclays upped their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 3rd. Eleven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $94.38.

Insider Buying and Selling

In other news, COO Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the transaction, the chief operating officer owned 10,415 shares of the company’s stock, valued at approximately $1,018,691.15. This represents a 59.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Sally Massey sold 15,851 shares of the firm’s stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares in the company, valued at $1,306,757.53. The trade was a 53.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 184,683 shares of company stock worth $17,486,693 over the last ninety days. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Trading Down 0.1%

NYSE:CL opened at $95.52 on Thursday. The company has a market capitalization of $77.00 billion, a P/E ratio of 36.46, a P/E/G ratio of 4.31 and a beta of 0.29. The stock’s 50 day moving average price is $84.94 and its 200 day moving average price is $82.11. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the previous year, the firm posted $0.91 earnings per share. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. On average, research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.2%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 79.39%.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.